
Oncology. |Biomarker Constellations for Cancer Diagnostics.
(in dev.) numares currently focuses its research on prostate, bladder and hepatic cellular cancer. The objective is to find metabolite biomarker profiles indicating the presence of cancer which could be used in diagnostic screening.
Our oncology biomarker development pipeline and all future test applications will be available for the AXINON® System which produces high-quality, standardized NMR spectra based on numares’ Magnetic Group Signaling (MGS®) technology.
The combination of MGS® technology with the AXINON® System allows for test-specific spectral analysis with highly-reproducible results. The test system is easy to use with one-step sample preparation with ready-to-use reagents requiring minimal operator interaction. The test system is fast and efficient with automation capabilities allowing short hands-on-time and high walk-away capability.